Breaking News Instant updates and real-time market news.

PCG

PG&E

$10.02 /

-0.67 (-6.27%)

10:33
05/01/20
05/01
10:33
05/01/20
10:33

PG&E says on track for court confirmation of plan of reorganization by June 30

Earlier, PG&E Corporation said it continues to make substantial progress in reorganization cases and remains on track for bankruptcy court confirmation of its plan of reorganization by June 30, allowing the company to participate in California's new go-forward wildfire fund. PG&E has previously reached settlements with all major groups of wildfire victims to be implemented pursuant to its Plan, valued at approximately $25.5B at plan value. Voting by eligible parties is now underway, and ballot counting is expected to be complete by the third week of May, the company said.

PCG PG&E
$10.02 /

-0.67 (-6.27%)

04/07/20 Mizuho
PG&E price target lowered to $12.50 from $15.50 at Mizuho
04/06/20 Mizuho
Mizuho expects PG&E share offering to price at 'significant premium'
04/02/20 Citi
Citi sees stock rally for PG&E, boosts price target to $17
03/31/20 Morgan Stanley
PG&E price target lowered to $10 from $16 at Morgan Stanley

TODAY'S FREE FLY STORIES

Upgrade
Itron upgraded to Buy from Hold at Argus » 07:19
03/03/21
03/03
07:19
03/03/21
07:19
ITRI

Itron

$117.75 /

-0.06 (-0.05%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRI Itron
$117.75 /

-0.06 (-0.05%)

ITRI Itron
$117.75 /

-0.06 (-0.05%)

02/25/21 Oppenheimer
Itron price target raised to $127 from $75 at Oppenheimer
01/08/21 Raymond James
Itron downgraded to Outperform from Strong Buy at Raymond James
01/08/21 Raymond James
Itron downgraded to Outperform from Strong Buy at Raymond James
10/15/20 Stephens
Itron resumed with an Overweight at Stephens
ITRI Itron
$117.75 /

-0.06 (-0.05%)

Initiation
BlackRock TCP Capital resumed with an Outperform at JMP Securities » 07:19
03/03/21
03/03
07:19
03/03/21
07:19
TCPC

BlackRock TCP Capital

/

+

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TCPC BlackRock TCP Capital
/

+

02/26/21 Raymond James
BlackRock TCP Capital upgraded to Outperform from Market Perform at Raymond James
02/26/21 Raymond James
BlackRock TCP upgraded to Outperform from Market Perform at Raymond James
06/24/20 Raymond James
TCP Capital downgraded to Market Perform from Outperform at Raymond James
06/24/20 Raymond James
TCP Capital downgraded to Market Perform from Outperform at Raymond James
TCPC BlackRock TCP Capital
/

+

Hot Stocks
Kamada closes aquisition of FDA-licensed plasma collection center » 07:19
03/03/21
03/03
07:19
03/03/21
07:19
KMDA

Kamada

$6.10 /

-0.1 (-1.61%)

Kamada updated that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KMDA Kamada
$6.10 /

-0.1 (-1.61%)

KMDA Kamada
$6.10 /

-0.1 (-1.61%)

08/14/20 Chardan
Kamada price target raised to $11 from $7 at Chardan
KMDA Kamada
$6.10 /

-0.1 (-1.61%)

KMDA Kamada
$6.10 /

-0.1 (-1.61%)

Upgrade
Roku upgraded to Overweight at KeyBanc on video monetization » 07:18
03/03/21
03/03
07:18
03/03/21
07:18
ROKU

Roku

$389.13 /

-31.09 (-7.40%)

, NLSN

Nielsen

$24.83 /

+1.74 (+7.54%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$389.13 /

-31.09 (-7.40%)

NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

ROKU Roku
$389.13 /

-31.09 (-7.40%)

04:40 Today KeyBanc
Roku upgraded to Overweight from Sector Weight at KeyBanc
02/22/21 Needham
Roku price target raised to $550 from $400 at Needham
02/19/21 Truist
Roku price target raised to $480 from $390 at Truist
02/19/21 JPMorgan
Roku price target raised to $525 from $475 at JPMorgan
NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

03/02/21 Truist
Nielsen price target raised to $26 from $20 at Truist
03/01/21 Truist
Nielsen price target raised to $26 from $20 at Truist
01/28/21 Citi
Nielsen price target raised to $27 from $22 at Citi
11/03/20 Deutsche Bank
Nielsen price target lowered to $18 from $22 at Deutsche Bank
ROKU Roku
$389.13 /

-31.09 (-7.40%)

NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

  • 17
    Mar
ROKU Roku
$389.13 /

-31.09 (-7.40%)

NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

ROKU Roku
$389.13 /

-31.09 (-7.40%)

NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

ROKU Roku
$389.13 /

-31.09 (-7.40%)

NLSN Nielsen
$24.83 /

+1.74 (+7.54%)

Recommendations
Stratasys price target raised to $34 from $14 at Loop Capital » 07:17
03/03/21
03/03
07:17
03/03/21
07:17
SSYS

Stratasys

$32.27 /

-4.12 (-11.32%)

Loop Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

01/19/21 Stifel
Stratasys initiated with a Buy at Stifel
01/15/21 JPMorgan
Stratasys downgraded to Underweight from Neutral at JPMorgan
10/09/20 Berenberg
Stratasys initiated with a Buy at Berenberg
09/24/20
Fly Intel: Top five analyst downgrades
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

  • 03
    Mar
SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

SSYS Stratasys
$32.27 /

-4.12 (-11.32%)

Hot Stocks
Qiwi CFO Pavel Korzh resigns » 07:17
03/03/21
03/03
07:17
03/03/21
07:17
QIWI

Qiwi

$11.11 /

+0.12 (+1.09%)

QIWI announced that Pavel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QIWI Qiwi
$11.11 /

+0.12 (+1.09%)

QIWI Qiwi
$11.11 /

+0.12 (+1.09%)

12/11/20 Goldman Sachs
Qiwi downgraded to Neutral from Buy at Goldman Sachs
12/10/20 William Blair
Qiwi government audit to bring business changes, says William Blair
12/09/20 JPMorgan
Qiwi downgraded to Underweight from Neutral at JPMorgan
11/23/20
Qiwi downgraded to Sell from Buy at Sberbank CIB
QIWI Qiwi
$11.11 /

+0.12 (+1.09%)

  • 22
    Jul
QIWI Qiwi
$11.11 /

+0.12 (+1.09%)

QIWI Qiwi
$11.11 /

+0.12 (+1.09%)

Recommendations
TTEC Holdings price target raised to $110 from $90 at Canaccord » 07:16
03/03/21
03/03
07:16
03/03/21
07:16
TTEC

TTEC Holdings

$86.51 /

-2.22 (-2.50%)

Canaccord analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TTEC TTEC Holdings
$86.51 /

-2.22 (-2.50%)

TTEC TTEC Holdings
$86.51 /

-2.22 (-2.50%)

12/17/20 Canaccord
TTEC Holdings price target raised to $90 from $77 at Canaccord
10/15/20 Canaccord
TTEC Holdings model steadily shifts to digital, Canaccord starts with a Buy
10/15/20 Canaccord
TTEC Holdings initiated with a Buy at Canaccord
08/10/20
Fly Intel: Top five analyst downgrades
TTEC TTEC Holdings
$86.51 /

-2.22 (-2.50%)

TTEC TTEC Holdings
$86.51 /

-2.22 (-2.50%)

Hot Stocks
Greenlane acquires Eyce, terms not disclosed » 07:16
03/03/21
03/03
07:16
03/03/21
07:16
GNLN

Greenlane

$5.74 /

+0.03 (+0.53%)

Greenlane Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GNLN Greenlane
$5.74 /

+0.03 (+0.53%)

GNLN Greenlane
$5.74 /

+0.03 (+0.53%)

03/31/20 Roth Capital
Greenlane price target lowered to $4 from $9 at Roth Capital
GNLN Greenlane
$5.74 /

+0.03 (+0.53%)

GNLN Greenlane
$5.74 /

+0.03 (+0.53%)

Hot Stocks
Atlas Technical Consultants to acquire Atlantic Engineering Laboratories » 07:15
03/03/21
03/03
07:15
03/03/21
07:15
ATCX

Atlas Technical Consultants

$9.20 /

-0.3 (-3.16%)

Atlas Technical…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATCX Atlas Technical Consultants
$9.20 /

-0.3 (-3.16%)

ATCX Atlas Technical Consultants
$9.20 /

-0.3 (-3.16%)

01/08/21
Fly Intel: Top five analyst initiations
01/08/21 Stifel
Atlas Technical Consultants initiated with a Buy at Stifel
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
08/11/20 DA Davidson
Atlas Technical Consultants upgraded to Buy from Neutral at DA Davidson
  • 14
    Aug
Recommendations
Kala recent selloff brings attractive entry point, says JPMorgan » 07:15
03/03/21
03/03
07:15
03/03/21
07:15
KALA

Kala Pharmaceuticals

/

+

JPMorgan analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KALA Kala Pharmaceuticals
/

+

KALA Kala Pharmaceuticals
/

+

10/28/20 Wedbush
Kala Pharmaceuticals price target raised to $47 from $39 at Wedbush
09/14/20
Fly Intel: Top five analyst downgrades
09/14/20 Jefferies
Jefferies downgrades Kala to Hold, cuts target to $10 following physician survey
09/14/20 Jefferies
Kala Pharmaceuticals downgraded to Hold from Buy at Jefferies
KALA Kala Pharmaceuticals
/

+

  • 11
    Mar
KALA Kala Pharmaceuticals
/

+

Recommendations
Sea Limited price target raised to $260 from $225 at Stifel » 07:15
03/03/21
03/03
07:15
03/03/21
07:15
SE

Sea Limited

$250.44 /

+1.635 (+0.66%)

Stifel analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SE Sea Limited
$250.44 /

+1.635 (+0.66%)

SE Sea Limited
$250.44 /

+1.635 (+0.66%)

02/23/21 Cowen
Sea Limited price target raised to $320 from $225 at Cowen
02/01/21 China Renaissance
Sea Limited initiated with a Buy at China Renaissance
02/01/21 Morgan Stanley
Sea Limited price target raised to $250 from $188 at Morgan Stanley
01/08/21 Stifel
Sea Group secures banking license in Indonesia, says Stifel
SE Sea Limited
$250.44 /

+1.635 (+0.66%)

  • 11
    Dec
SE Sea Limited
$250.44 /

+1.635 (+0.66%)

SE Sea Limited
$250.44 /

+1.635 (+0.66%)

SE Sea Limited
$250.44 /

+1.635 (+0.66%)

Hot Stocks
Zoom Video rises after one of Cathie Wood's ARK ETFs discloses holdings » 07:15
03/03/21
03/03
07:15
03/03/21
07:15
ZM

Zoom Video

$372.72 /

-36.95 (-9.02%)

Shares of Zoom Video (ZM)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

03/02/21
Fly Intel: Top five analyst upgrades
03/02/21 Morgan Stanley
Zoom Video price target raised to $420 from $390 at Morgan Stanley
03/02/21 Piper Sandler
Zoom Video upgraded to Overweight from Neutral at Piper Sandler
01/26/21 MKM Partners
Fiverr downgraded to Sell from Neutral at MKM Partners
ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

  • 13
    Jan
ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

ZM Zoom Video
$372.72 /

-36.95 (-9.02%)

Hot Stocks
Actinium Pharmaceuticals appoints Mark Kubik as Chief Business Office » 07:15
03/03/21
03/03
07:15
03/03/21
07:15
ATNM

Actinium Pharmaceuticals

$8.15 /

+0.1 (+1.24%)

Actinium Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATNM Actinium Pharmaceuticals
$8.15 /

+0.1 (+1.24%)

ATNM Actinium Pharmaceuticals
$8.15 /

+0.1 (+1.24%)

12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
11/05/20 Alliance Global Partners
Actinium Pharmaceuticals initiated with a Buy at Alliance Global Partners
  • 17
    Jun
  • 22
    Apr
ATNM Actinium Pharmaceuticals
$8.15 /

+0.1 (+1.24%)

Recommendations
TransMedics price target raised to $46 from $20 at Canaccord » 07:14
03/03/21
03/03
07:14
03/03/21
07:14
TMDX

TransMedics

$39.55 /

+3.305 (+9.12%)

Canaccord analyst Cecilia…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TMDX TransMedics
$39.55 /

+3.305 (+9.12%)

TMDX TransMedics
$39.55 /

+3.305 (+9.12%)

03/02/21 Oppenheimer
TransMedics price target raised to $40 from $25 at Oppenheimer
02/24/21 Cowen
TransMedics price target raised to $44 from $20 at Cowen
10/08/20
Fly Intel: Top five analyst downgrades
10/08/20 JPMorgan
TransMedics downgraded to Neutral on 'missed' execution at JPMorgan
TMDX TransMedics
$39.55 /

+3.305 (+9.12%)

  • 27
    May
TMDX TransMedics
$39.55 /

+3.305 (+9.12%)

Hot Stocks
BioXcel schedules End of Phase 2 meeting for BXCL501 in 2Q21 » 07:14
03/03/21
03/03
07:14
03/03/21
07:14
BTAI

BioXcel Therapeutics

$52.76 /

-2.735 (-4.93%)

BioXcel Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTAI BioXcel Therapeutics
$52.76 /

-2.735 (-4.93%)

BTAI BioXcel Therapeutics
$52.76 /

-2.735 (-4.93%)

02/01/21 UBS
BioXcel Therapeutics initiated with a Buy at UBS
01/06/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $185 from $175 at H.C. Wainwright
10/30/20
Fly Intel: Top five analyst initiations
10/30/20 Goldman Sachs
BioXcel Therapeutics initiated with a Buy at Goldman Sachs
BTAI BioXcel Therapeutics
$52.76 /

-2.735 (-4.93%)

  • 29
    Jul
BTAI BioXcel Therapeutics
$52.76 /

-2.735 (-4.93%)

Recommendations
Ambarella price target raised to $135 from $128 at Stifel » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
AMBA

Ambarella

/

+

Stifel analyst Tore…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMBA Ambarella
/

+

AMBA Ambarella
/

+

02/24/21 Deutsche Bank
Ambarella price target raised to $100 from $75 at Deutsche Bank
01/21/21 Stifel
Ambarella price target raised to $118 from $110 at Stifel
01/13/21 Roth Capital
Ambarella upgraded to Buy with $130 price target at Roth Capital
01/13/21 Roth Capital
Ambarella upgraded to Buy from Neutral at Roth Capital
AMBA Ambarella
/

+

AMBA Ambarella
/

+

AMBA Ambarella
/

+

Recommendations
Quanterix price target raised to $90 from $86 at Canaccord » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
QTRX

Quanterix

$77.06 /

-5.61 (-6.79%)

Canaccord analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

01/27/21 SVB Leerink
Quanterix price target raised to $75 from $50 at SVB Leerink
01/14/21 Canaccord
Quanterix price target raised to $74 from $60 at Canaccord
01/12/21 Canaccord
Quanterix price target raised to $60 from $54 at Canaccord
10/19/20 SVB Leerink
Quanterix price target raised to $48 from $37 at SVB Leerink
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

  • 04
    Feb
  • 07
    Aug
QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

QTRX Quanterix
$77.06 /

-5.61 (-6.79%)

Hot Stocks
Charlotte's Web to enter U.S. cannabis wellness market » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
CWBHF

Charlotte's Web

$0.00 /

+ (+0.00%)

Charlotte's Web…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

09/15/20 Piper Sandler
Charlotte's Web price target lowered to $4 from $7 at Piper Sandler
06/12/20 Cowen
Charlotte's Web initiated with an Outperform at Cowen
03/23/20 Canaccord
Charlotte's Web price target lowered to C$10 from C$17 at Canaccord
03/09/20 Cantor Fitzgerald
Charlotte's Web price target lowered to $7 from $11.70 at Cantor Fitzgerald
CWBHF Charlotte's Web
$0.00 /

+ (+0.00%)

Downgrade
Singapore Airlines downgraded to Neutral from Overweight at JPMorgan » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
SINGY

Singapore Airlines

$0.00 /

+ (+0.00%)

JPMorgan analyst Karen Li…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SINGY Singapore Airlines
$0.00 /

+ (+0.00%)

12/15/20 DBS Bank
Singapore Airlines downgraded to Fully Valued from Hold at DBS Bank
11/10/20 JPMorgan
Singapore Airlines upgraded to Overweight from Underweight at JPMorgan
11/09/20 Goldman Sachs
Singapore Airlines upgraded to Neutral from Sell at Goldman Sachs
07/30/20 CIMB
Singapore Airlines downgraded to Hold from Add at CIMB
Hot Stocks
Passage Bio announces anticipated upcoming milestones » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
PASG

Passage Bio

$19.58 /

+ (+0.00%)

Anticipated Upcoming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.58 /

+ (+0.00%)

PASG Passage Bio
$19.58 /

+ (+0.00%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Guggenheim
Passage Bio initiated with a Buy at Guggenheim
01/25/21 Citi
Citi upgrades Passage Bio to Buy after pullback and ahead of data
01/25/21 Citi
Passage Bio upgraded to Buy from Neutral at Citi
PASG Passage Bio
$19.58 /

+ (+0.00%)

  • 22
    Jan
PASG Passage Bio
$19.58 /

+ (+0.00%)

PASG Passage Bio
$19.58 /

+ (+0.00%)

Hot Stocks
Marker Therapeutics doses first patient in Phase 2 trial of MT-401 in AML » 07:12
03/03/21
03/03
07:12
03/03/21
07:12
MRKR

Marker Therapeutics

$2.50 /

-0.04 (-1.57%)

Marker Therapeutics has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRKR Marker Therapeutics
$2.50 /

-0.04 (-1.57%)

MRKR Marker Therapeutics
$2.50 /

-0.04 (-1.57%)

01/05/21 Oppenheimer
Marker hits 'important milestone' with end of clinical hold, says Oppenheimer
05/12/20
Fly Intel: Top five analyst downgrades
05/12/20 Piper Sandler
Marker Therapeutics downgraded to Neutral from Overweight at Piper Sandler
MRKR Marker Therapeutics
$2.50 /

-0.04 (-1.57%)

Earnings
Passage Bio reports Q4 EPS (85c), consensus (70c) » 07:11
03/03/21
03/03
07:11
03/03/21
07:11
PASG

Passage Bio

$19.58 /

+ (+0.00%)

"At Passage Bio, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$19.58 /

+ (+0.00%)

PASG Passage Bio
$19.58 /

+ (+0.00%)

02/04/21
Fly Intel: Top five analyst initiations
02/04/21 Guggenheim
Passage Bio initiated with a Buy at Guggenheim
01/25/21 Citi
Citi upgrades Passage Bio to Buy after pullback and ahead of data
01/25/21 Citi
Passage Bio upgraded to Buy from Neutral at Citi
PASG Passage Bio
$19.58 /

+ (+0.00%)

  • 22
    Jan
PASG Passage Bio
$19.58 /

+ (+0.00%)

PASG Passage Bio
$19.58 /

+ (+0.00%)

Recommendations
Pulmonx price target raised to $65 from $49 at Canaccord » 07:11
03/03/21
03/03
07:11
03/03/21
07:11
LUNG

Pulmonx

$57.93 /

-2.37 (-3.93%)

Canaccord analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LUNG Pulmonx
$57.93 /

-2.37 (-3.93%)

LUNG Pulmonx
$57.93 /

-2.37 (-3.93%)

01/04/21 BofA
Pulmonx downgraded to Neutral from Buy at BofA
10/26/20 BofA
Pulmonx initiated with a Buy at BofA
10/26/20 Canaccord
Pulmonx initiated with a Buy at Canaccord
10/26/20 Morgan Stanley
Pulmonx initiated with an Equal Weight at Morgan Stanley
LUNG Pulmonx
$57.93 /

-2.37 (-3.93%)

  • 01
    Oct
LUNG Pulmonx
$57.93 /

-2.37 (-3.93%)

LUNG Pulmonx
$57.93 /

-2.37 (-3.93%)

Earnings
Taysha Gene Therapies reports Q4 EPS (12c), consensus (37c) » 07:10
03/03/21
03/03
07:10
03/03/21
07:10
TSHA

Taysha Gene Therapies

$25.78 /

-0.99 (-3.70%)

Cash and cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TSHA Taysha Gene Therapies
$25.78 /

-0.99 (-3.70%)

TSHA Taysha Gene Therapies
$25.78 /

-0.99 (-3.70%)

02/23/21 William Blair
William Blair starts Taysha with Outperform, $46 fair-value estimate
02/23/21 William Blair
William Blair starts Taysha Gene Therapies with Outperform on positive FDA draft
02/23/21 William Blair
Taysha Gene Therapies initiated with an Outperform at William Blair
01/04/21 Oppenheimer
Taysha Gene Therapies initiated with an Outperform at Oppenheimer
  • 24
    Sep
TSHA Taysha Gene Therapies
$25.78 /

-0.99 (-3.70%)

Hot Stocks
Carrols Restaurant targets 2021 net capital expenditures approx. $60M » 07:10
03/03/21
03/03
07:10
03/03/21
07:10
TAST

Carrols Restaurant

$6.55 /

+0.16 (+2.50%)

Daniel T. Accordino,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAST Carrols Restaurant
$6.55 /

+0.16 (+2.50%)

TAST Carrols Restaurant
$6.55 /

+0.16 (+2.50%)

01/15/21 BMO Capital
Restaurant Brands price target raised to $70 from $65 at BMO Capital
01/15/21 Deutsche Bank
Carrols Restaurant price target raised to $8 from $7 at Deutsche Bank
01/12/21 Baird
Baird cautious Restaurant Brands ahead of results
11/09/20 Deutsche Bank
Carrols Restaurant price target lowered to $7 from $8 at Deutsche Bank
TAST Carrols Restaurant
$6.55 /

+0.16 (+2.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.